返回 Agenda
Session Chair(s)
Brenda Crowe, PHD
Associate Vice President, Statistics
Eli Lilly and Company, United States
Aloka Chakravarty, PHD
Director, Data Analytics
Office of Data, Analytics, & Research, Office of the Commissioner, FDA, United States
Speaker(s)
Network Meta-Analysis for Safety Assessment
Christopher H. Schmid, PHD
Brown University School of Public Health, United States
Professor of Biostatistics, Center for Evidence Based Medicine
Panelists
Mark Levenson, PHD
FDA, United States
Director, Division of Biometrics VII, Office of Biostatistics, OT, CDER
Jesse Berlin, DRSC
Johnson & Johnson, United States
Senior Vice President, Epidemiology
Amy Xia, PHD
Amgen Inc., United States
Vice President, Center for Design and Analysis